FDA faults quality control at Eli Lilly plant
FDA faults quality control at Eli Lilly plant

U.S. drug inspectors uncovered serious quality control problems at an Eli Lilly pharmaceutical plant that is ramping up to manufacture one of two promising COVID-19 drugs touted by President Trump as "a cure" for the disease, according to government documents and three sources familiar with the matter.

Jillian Kitchener reports